Suicide Treatment and Recovery in Integrated Behavioral Health (STRIBH)
Launched by UNIVERSITY OF WASHINGTON · Nov 20, 2024
Trial Information
Current as of November 14, 2025
Not yet recruiting
Keywords
ClinConnect Summary
The STRIBH trial is studying a new approach to help adolescents and young adults, ages 13 to 30, who are experiencing suicidal thoughts or have attempted suicide in the past year. The goal is to improve their care by combining a model called the "Aeschi Model" with Collaborative Care, which focuses on integrating mental health support within regular primary care settings. This study aims to see if this new "Connections model" can help strengthen the relationship between patients and their healthcare providers, making it easier for both to work together on mental health issues, while also reducing the risk of suicide.
To be eligible for the trial, participants need to be between 13 and 30 years old, have experienced suicidal thoughts or attempts in the past year, and not need immediate crisis care. They must also be able to read one of the four most common languages in Seattle—English, Spanish, Chinese, or Vietnamese—and be enrolled in a primary care clinic that has a mental health provider available. Those who join the study can expect to receive support through this new approach while helping researchers understand whether it effectively improves mental health outcomes and the overall experience of care. This trial is not yet recruiting participants, but it aims to make a significant impact in the field of suicide prevention.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 13-30 years of age, experiencing suicidal thoughts or attempted suicide in the past year, not requiring immediate crisis care (as determined by the UW Primary Care team), not enrolled in specialty behavioral health treatment, can read one of the 4 most common languages in Seattle (English, Spanish, Chinese, or Vietnamese), enrolled in a primary care clinic with an integrated behavioral health provider available to see them, and ability to consent to participate.
- Exclusion Criteria:
- • any clinical medical/psychiatric condition, severity of that condition, or life situation that, in the opinion of the primary care or research team, compromises safe and voluntary study participation (e.g., high risk for suicide requiring transfer to higher level of care; physically aggressive, custody conflict)
About University Of Washington
The University of Washington (UW) is a leading academic institution renowned for its commitment to advancing healthcare through innovative research and clinical trials. With a robust network of interdisciplinary teams, UW fosters collaboration among top-tier researchers, clinicians, and healthcare professionals, aiming to translate scientific discoveries into impactful treatments and interventions. The university is dedicated to ethical research practices and participant safety, ensuring rigorous adherence to regulatory standards in all clinical trials. Through its state-of-the-art facilities and extensive expertise, UW strives to address pressing health challenges and improve patient outcomes on a local and global scale.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Katherine A Comtois, PhD, MPH
Principal Investigator
University of Washington
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported